Cargando…
Fetal adverse effects following NSAID or metamizole exposure in the 2nd and 3rd trimester: an evaluation of the German Embryotox cohort
BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAID) are frequently used to treat pain, fever and inflammatory conditions. Due to evidenced fetotoxicity, treatment with NSAID and metamizole should be avoided in the 3rd trimester of pregnancy. There is an ongoing debate on fetotoxic risk of 2nd...
Autores principales: | Dathe, Katarina, Frank, Johanna, Padberg, Stephanie, Hultzsch, Stefanie, Beck, Evelin, Schaefer, Christof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413886/ https://www.ncbi.nlm.nih.gov/pubmed/36028798 http://dx.doi.org/10.1186/s12884-022-04986-4 |
Ejemplares similares
-
Ivabradine use in pregnant women—treatment indications and pregnancy outcome: an evaluation of the German Embryotox database
por: Hoeltzenbein, Maria, et al.
Publicado: (2021) -
Parenteral Ready-to-Use Fixed-Dose Combinations Including NSAIDs with Paracetamol or Metamizole for Multimodal Analgesia—Approved Products and Challenges
por: Silva, Fernando, et al.
Publicado: (2023) -
Sildenafil during the 2nd and 3rd Trimester of Pregnancy: Trials and Tribulations
por: De Bie, Felix Rafael, et al.
Publicado: (2022) -
Embryotoxicity and Toxicokinetics of the Antimalarial Artesunate in Rats
por: Chung, Moon-Koo, et al.
Publicado: (2013) -
Embryotoxic and Teratogenic Effects of Tartrazine in Rats
por: Hashem, Mohamed Mohammed, et al.
Publicado: (2019)